ATE528025T1 - Wachstumsfaktor-modifiziertes extrazelluläres matrixmaterial und verfahren zu seiner herstellung und verwendung - Google Patents
Wachstumsfaktor-modifiziertes extrazelluläres matrixmaterial und verfahren zu seiner herstellung und verwendungInfo
- Publication number
- ATE528025T1 ATE528025T1 AT08747004T AT08747004T ATE528025T1 AT E528025 T1 ATE528025 T1 AT E528025T1 AT 08747004 T AT08747004 T AT 08747004T AT 08747004 T AT08747004 T AT 08747004T AT E528025 T1 ATE528025 T1 AT E528025T1
- Authority
- AT
- Austria
- Prior art keywords
- extracellular matrix
- production
- growth factor
- matrix material
- graft
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 title abstract 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 title abstract 2
- 210000002744 extracellular matrix Anatomy 0.000 title abstract 2
- 239000003102 growth factor Substances 0.000 title abstract 2
- 239000011159 matrix material Substances 0.000 title abstract 2
- 239000000463 material Substances 0.000 abstract 3
- 210000001519 tissue Anatomy 0.000 abstract 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 229960002897 heparin Drugs 0.000 abstract 1
- 229920000669 heparin Polymers 0.000 abstract 1
- 102000022382 heparin binding proteins Human genes 0.000 abstract 1
- 108091012216 heparin binding proteins Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000000717 retained effect Effects 0.000 abstract 1
- 210000004876 tela submucosa Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3633—Extracellular matrix [ECM]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Botany (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Prostheses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91448507P | 2007-04-27 | 2007-04-27 | |
| PCT/US2008/061727 WO2008134610A1 (en) | 2007-04-27 | 2008-04-28 | Growth factor modified extracellular matrix material and methods for preparation and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE528025T1 true ATE528025T1 (de) | 2011-10-15 |
Family
ID=39580395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08747004T ATE528025T1 (de) | 2007-04-27 | 2008-04-28 | Wachstumsfaktor-modifiziertes extrazelluläres matrixmaterial und verfahren zu seiner herstellung und verwendung |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US8591930B2 (de) |
| EP (1) | EP2150283B1 (de) |
| AT (1) | ATE528025T1 (de) |
| WO (1) | WO2008134610A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8679176B2 (en) | 2007-12-18 | 2014-03-25 | Cormatrix Cardiovascular, Inc | Prosthetic tissue valve |
| US8257434B2 (en) | 2007-12-18 | 2012-09-04 | Cormatrix Cardiovascular, Inc. | Prosthetic tissue valve |
| EP2113261B1 (de) * | 2008-04-29 | 2013-11-06 | Proxy Biomedical Limited | Gewebereparaturimplantat |
| CA2752899A1 (en) | 2009-02-18 | 2010-08-26 | Cormatrix Cardiovascular, Inc. | Compositions and methods for preventing cardiac arrhythmia |
| CA2835863A1 (en) | 2011-05-27 | 2012-12-06 | Cormatrix Cardiovascular, Inc. | Sterilized, acellular extracellular matrix compositions and methods of making thereof |
| JP5902827B2 (ja) | 2011-12-09 | 2016-04-13 | アセル,インコーポレイテッド | 止血装置 |
| EP2798057B1 (de) * | 2011-12-30 | 2018-08-22 | Vivex Biomedical, Inc. | Regenerative gewebematrix |
| WO2015148723A1 (en) | 2014-03-25 | 2015-10-01 | Cook Biotech Incorporated | Extracellular matrix grafts loaded with exogenous factors |
| US9238090B1 (en) | 2014-12-24 | 2016-01-19 | Fettech, Llc | Tissue-based compositions |
| US11633520B2 (en) | 2017-03-06 | 2023-04-25 | Tei Biosciences, Inc. | Perforated tissue graft |
| CN112462062B (zh) * | 2020-04-20 | 2023-10-03 | 沈阳艾米奥生物工程技术研发中心有限公司 | 一种羊膜干细胞外分泌蛋白的筛选鉴定方法及应用 |
| US11826490B1 (en) | 2020-12-29 | 2023-11-28 | Acell, Inc. | Extracellular matrix sheet devices with improved mechanical properties and method of making |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2127903A (en) * | 1936-05-05 | 1938-08-23 | Davis & Geck Inc | Tube for surgical purposes and method of preparing and using the same |
| US2167251A (en) * | 1938-08-20 | 1939-07-25 | Davis & Geck Inc | Surgical tape of submucosa tissue |
| US3272204A (en) * | 1965-09-22 | 1966-09-13 | Ethicon Inc | Absorbable collagen prosthetic implant with non-absorbable reinforcing strands |
| US4321914A (en) * | 1980-04-22 | 1982-03-30 | W. L. Gore & Associates, Inc. | Percutaneous conduit having PTFE skirt |
| US4801299A (en) * | 1983-06-10 | 1989-01-31 | University Patents, Inc. | Body implants of extracellular matrix and means and methods of making and using such implants |
| US4781176A (en) * | 1987-02-20 | 1988-11-01 | Biagio Ravo | Implantable device |
| US4969902A (en) * | 1987-02-20 | 1990-11-13 | Biagio Ravo | Implantable device |
| US5294551A (en) * | 1987-08-25 | 1994-03-15 | Regents Of The University Of Minnesota | Cell culture substrate coated with polypeptides having fibronectin activity |
| US4950483A (en) * | 1988-06-30 | 1990-08-21 | Collagen Corporation | Collagen wound healing matrices and process for their production |
| US4902508A (en) * | 1988-07-11 | 1990-02-20 | Purdue Research Foundation | Tissue graft composition |
| US4956178A (en) * | 1988-07-11 | 1990-09-11 | Purdue Research Foundation | Tissue graft composition |
| US5281422A (en) * | 1991-09-24 | 1994-01-25 | Purdue Research Foundation | Graft for promoting autogenous tissue growth |
| US5269774A (en) * | 1992-09-25 | 1993-12-14 | Gray Michael W | Implantive ostomy ring |
| JPH09510108A (ja) | 1994-03-14 | 1997-10-14 | クリオライフ,インコーポレイティド | 移植用処理組織及び調製方法 |
| US6475232B1 (en) | 1996-12-10 | 2002-11-05 | Purdue Research Foundation | Stent with reduced thrombogenicity |
| US5711969A (en) * | 1995-04-07 | 1998-01-27 | Purdue Research Foundation | Large area submucosal tissue graft constructs |
| US5554389A (en) * | 1995-04-07 | 1996-09-10 | Purdue Research Foundation | Urinary bladder submucosa derived tissue graft |
| CZ54899A3 (cs) * | 1996-08-23 | 1999-08-11 | Cook Biotech, Incorporated | Štěpová protéza, materiály s ní spojené a způsoby její výroby |
| US6099567A (en) * | 1996-12-10 | 2000-08-08 | Purdue Research Foundation | Stomach submucosa derived tissue graft |
| US5958874A (en) * | 1998-02-18 | 1999-09-28 | The Research Foundation Of State University Of New York | Recombinant fibronectin-based extracellular matrix for wound healing |
| JP2005515802A (ja) * | 2001-07-16 | 2005-06-02 | デピュイ・プロダクツ・インコーポレイテッド | 混成生物/合成品型多孔質細胞外基質支持骨格 |
| US7550004B2 (en) * | 2002-08-20 | 2009-06-23 | Cook Biotech Incorporated | Endoluminal device with extracellular matrix material and methods |
| US20070141101A1 (en) * | 2003-04-10 | 2007-06-21 | The Trustees Of Boston University | Method for stimulating angiogenesis and wound healing |
| US20050079611A1 (en) * | 2003-08-20 | 2005-04-14 | Min Wu | Modified reconstituted basement membrane composition for assay system |
| NZ552788A (en) * | 2004-07-22 | 2010-04-30 | Prochon Biotech Ltd | Porous plasma protein matrices and methods for preparation thereof |
| WO2006044512A1 (en) * | 2004-10-15 | 2006-04-27 | Cook Biotech Incorporated | Fibronectin-modified ecm tissue graft constructs and methods for preparation and use thereof |
| US7871440B2 (en) * | 2006-12-11 | 2011-01-18 | Depuy Products, Inc. | Unitary surgical device and method |
-
2008
- 2008-04-28 US US12/110,630 patent/US8591930B2/en not_active Expired - Fee Related
- 2008-04-28 EP EP08747004A patent/EP2150283B1/de active Active
- 2008-04-28 AT AT08747004T patent/ATE528025T1/de not_active IP Right Cessation
- 2008-04-28 WO PCT/US2008/061727 patent/WO2008134610A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US8591930B2 (en) | 2013-11-26 |
| EP2150283A1 (de) | 2010-02-10 |
| US20080299171A1 (en) | 2008-12-04 |
| WO2008134610A8 (en) | 2009-01-29 |
| WO2008134610A1 (en) | 2008-11-06 |
| EP2150283B1 (de) | 2011-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE528025T1 (de) | Wachstumsfaktor-modifiziertes extrazelluläres matrixmaterial und verfahren zu seiner herstellung und verwendung | |
| Kim et al. | Shear-induced alignment of collagen fibrils using 3D cell printing for corneal stroma tissue engineering | |
| Bjork et al. | Ruthenium-catalyzed photo cross-linking of fibrin-based engineered tissue | |
| Sood et al. | Fetal brain extracellular matrix boosts neuronal network formation in 3D bioengineered model of cortical brain tissue | |
| Philandrianos et al. | Comparison of five dermal substitutes in full-thickness skin wound healing in a porcine model | |
| Stoppel et al. | Elastic, silk‐cardiac extracellular matrix hydrogels exhibit time‐dependent stiffening that modulates cardiac fibroblast response | |
| Chae et al. | Mechanically and biologically promoted cell-laden constructs generated using tissue-specific bioinks for tendon/ligament tissue engineering applications | |
| WO2012002986A3 (en) | Decellularized and delipidized extracellular matrix and methods of use | |
| Kober et al. | Generation of a fibrin based three‐layered skin substitute | |
| Lin et al. | Evaluation of decellularized extracellular matrix of skeletal muscle for tissue engineering | |
| Rennert et al. | Cellular response to a novel fetal acellular collagen matrix: implications for tissue regeneration | |
| AU2014341866B2 (en) | Methods of removing alpha-galactose | |
| Phang et al. | Advancements in extracellular matrix-based biomaterials and biofabrication of 3D organotypic skin models | |
| Koo et al. | Preconditioning process for dermal tissue decellularization using electroporation with sonication | |
| ATE500319T1 (de) | Verfahren zur verwendung von aus fettgewebe stammenden zellen bei der behandlung von herz- kreislauf-leiden | |
| Rodriguez et al. | Development of a mechanically tuneable 3D scaffold for vascular reconstruction | |
| CN104684593B (zh) | 用于生产胶原蛋白膜的方法及其应用 | |
| Panayi et al. | Novel application of autologous micrografts in a collagen-glycosaminoglycan scaffold for diabetic wound healing | |
| Nilsen et al. | Do processing methods make a difference in acellular dermal matrix properties? | |
| ATE395924T1 (de) | Wiederherstellung zerstörten gewebes mit hilfe von multipotenten zellen | |
| Hazwani et al. | Characterization and in vivo study of decellularized aortic scaffolds using closed sonication system | |
| Angelidis et al. | Tissue engineering of flexor tendons: the effect of a tissue bioreactor on adipoderived stem cell–seeded and fibroblast-seeded tendon constructs | |
| GB2434105A (en) | Fibronectin-modified ECM tissue graft constructs and methods for preparation and use thereof | |
| GB2456270B8 (en) | Skin substitutes, preparation methods and uses thereof | |
| Qi et al. | Construction and characterization of human oral mucosa equivalent using hyper-dry amniotic membrane as a matrix |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |